Review Article
The Aptamer Functionalized Nanocomposite Used for Prostate Cancer Diagnosis and Therapy
Table 2
Part of prostate cancer cell-specific aptamers sequences.
| Aptamer names | Aptamer sequence (5-3) |
| A9 | GGGAGGACGAUGCGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCCAGACGACUCGCCCGA [17] | A10 | GGGAGGACGAUGCGGAUCAGCCAUGUUUACGUCACUCCUUGUCAAUCCUCAUCGGC [40] | A10-3.2 | GGGAGGACGAUGCGGAUCAGCCAUGUUUACGUCACUCCU [19] | Wy-5a | TGCCACTACAGCTGGTTCGGTTTGGTGACTTCGTTCTTCGTTGTGGTGCTTAGTGGC [21] | DML-7 | ACGCTCGGATGCCACTACAGGTTGGGGTCGGGCATGCGTCCGGAGAAGGGCAAACGAGAGGTCACCAGCACGTCCATGAG [22] | CSC1 | ACCTTGGCTGTCGTGTTGTAGGTGGTTTGCTGCGGTGGGCTCAAGAAGAAAGCGCAAAGGTCAGTG GTCAGAGCGT [24] | CSC13 | ACCTTGGCTGTCGTGTTGTGGGGTGTCGTATCTTTCGTGTCTTATTATTTTCTAGGTGGA GGTCAGTGGTCAGAGCGT [24] | AMH | GCCGTATGGTACACGGTGTTCTAAACTATAAGAACACCGTGTACCATACGGC [23] | S2.2 anti-MUC1 aptamer | CAGTTGATCCTTTGGATACCCTG [41] | AS1411 | GGTGGTGGTGGTTGTGGTGGTGGTGG [40] |
|
|